Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Long-Term Debt Repayments (2016 - 2025)

Surgery Partners' Long-Term Debt Repayments history spans 12 years, with the latest figure at $579.4 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments rose 239.82% year-over-year to $579.4 million; the TTM value through Dec 2025 reached $1.0 billion, down 18.72%, while the annual FY2025 figure was $1.0 billion, 18.72% down from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $579.4 million at Surgery Partners, up from $161.0 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $853.6 million in Q2 2024 and bottomed at $14.8 million in Q4 2021.
  • The 5-year median for Long-Term Debt Repayments is $119.8 million (2024), against an average of $216.6 million.
  • The largest annual shift saw Long-Term Debt Repayments crashed 94.43% in 2022 before it surged 5371.79% in 2024.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $14.8 million in 2021, then skyrocketed by 5173.65% to $780.5 million in 2022, then decreased by 10.31% to $700.0 million in 2023, then plummeted by 75.64% to $170.5 million in 2024, then soared by 239.82% to $579.4 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Long-Term Debt Repayments are $579.4 million (Q4 2025), $161.0 million (Q3 2025), and $180.1 million (Q2 2025).